Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
J Neonatal Perinatal Med ; 13(2): 247-251, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-31796688

RESUMO

BACKGROUND: Healthcare spending is expected to grow faster than the economy over the next decade, and the cost of prematurity increases annually. The aim of this study was to investigate the frequency of intervention after routine laboratory testing in preterm infants. METHODS: This was a retrospective study of preterm infants (≤34 weeks) admitted to the NYU Langone Health NICU from June 2013 to December 2014. Data collected included demographics, results of laboratory tests, and resulting interventions. Intervention after a hemogram was defined as a blood transfusion. Intervention after a hepatic panel was defined as initiation or termination of ursodiol or change in dose of vitamin D. Subjects were stratified into 3 groups based on gestation (<28 weeks, 28-31 6/7 weeks, 32-34 weeks). Chi-square analysis was used to compare the frequency of intervention between the groups. RESULTS: A total of 135 subjects were included in the study. The frequency of intervention after a hemogram was 8.4% in infants <28 weeks, 4.6% in infants 28-31 6/7 weeks, and 0% in infants 32-34 weeks; this difference was found to be statistically significant (p = 0.02). The frequency of intervention after a hepatic panel was 4.2% in infants <28 weeks, 5.7% in infants 28-31 6/7 weeks, and 0% in infants 32-34 weeks, which was not found to be a statistically significant different. CONCLUSION: No interventions were undertaken post-routine laboratory testing in any infant 32-34 weeks and routine testing in this population may be unnecessary. Further studies are needed to elucidate if routine testing affects neonatal outcomes.


Assuntos
Anemia/diagnóstico , Conservadores da Densidade Óssea/administração & dosagem , Doenças Ósseas Metabólicas/diagnóstico , Colagogos e Coleréticos/uso terapêutico , Colestase/diagnóstico , Testes Diagnósticos de Rotina/métodos , Fosfatase Alcalina/sangue , Anemia/sangue , Anemia/terapia , Bilirrubina/sangue , Doenças Ósseas Metabólicas/sangue , Doenças Ósseas Metabólicas/tratamento farmacológico , Colestase/sangue , Colestase/tratamento farmacológico , Colestase/etiologia , Testes Diagnósticos de Rotina/economia , Transfusão de Eritrócitos/estatística & dados numéricos , Feminino , Idade Gestacional , Custos de Cuidados de Saúde , Gastos em Saúde , Hematócrito/economia , Hematócrito/métodos , Humanos , Lactente Extremamente Prematuro , Recém-Nascido , Recém-Nascido Prematuro , Unidades de Terapia Intensiva Neonatal , Testes de Função Hepática/economia , Testes de Função Hepática/métodos , Masculino , Programas de Rastreamento/economia , Programas de Rastreamento/métodos , Nutrição Parenteral Total/efeitos adversos , Seleção de Pacientes , Estudos Retrospectivos , Ácido Ursodesoxicólico/uso terapêutico , Vitamina D/administração & dosagem
2.
J Ayub Med Coll Abbottabad ; 13(2): 3-4, 2001.
Artigo em Inglês | MEDLINE | ID: mdl-11732218

RESUMO

BACKGROUND: 28-43% of the patients develop posterior capsular thickening after extra capsular cataract surgery. Nd-YAG laser capsulatomy is a method of choice to treat this complication. METHOD: We conducted a prospective clinical, randomized comparative study to evaluate the post YAG laser IOP rise in 54 patients at Ayub Teaching Hospital Complex. RESULT: There were 43% male and 57% female patients with a mean age of 63.6 years. The mean time for capsular opacification was 14.6 months. Postoperative visual improvement was 6/24 to 6/6. All patients showed post laser IOP rise that was controlled by Topical Beta-blockers and steroids effectively.


Assuntos
Antagonistas Adrenérgicos beta/uso terapêutico , Extração de Catarata/efeitos adversos , Terapia a Laser/efeitos adversos , Hipertensão Ocular/tratamento farmacológico , Esteroides/uso terapêutico , Adolescente , Antagonistas Adrenérgicos beta/administração & dosagem , Adulto , Idoso , Idoso de 80 Anos ou mais , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Hipertensão Ocular/etiologia , Estudos Prospectivos , Esteroides/administração & dosagem
4.
Oral Dis ; 8 Suppl 2: 169-75, 2002.
Artigo em Inglês | MEDLINE | ID: mdl-12164652

RESUMO

Oral fluids are rarely a vehicle for HIV-1 infection in vivo, unlike other mucosal secretions. This unique property raises questions regarding (1) the molecular mechanisms responsible for the lack of salivary transmission, (2) the extent to which oral immunological responses mirror responses at other mucosal sites, (3) the use of promising salivary markers of HIV-1 disease progression, (4) the relationship between oral and blood viral loads, (5) cofactors that influence oro-genital transmission, and (6) the feasibility of oral-based antibody testing for HIV-1 diagnosis in the home. This paper discusses these questions and provides background summaries, findings from new studies, consensus opinions, practical relevance to developing countries, and suggestions for future research agenda on each of the key topics.


Assuntos
Infecções por HIV/fisiopatologia , HIV-1/fisiologia , Saliva/fisiologia , Anticorpos Antivirais/análise , Antígenos Virais/imunologia , Antivirais/farmacologia , Biomarcadores/análise , Países em Desenvolvimento , Progressão da Doença , Estudos de Viabilidade , Infecções por HIV/transmissão , HIV-1/imunologia , Humanos , Imunidade nas Mucosas/imunologia , Mucosa Bucal/imunologia , Kit de Reagentes para Diagnóstico , Saliva/química , Saliva/imunologia , Saliva/virologia , Proteínas e Peptídeos Salivares/imunologia , Comportamento Sexual , Carga Viral , Viremia/virologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA